Blood Pressure Medications Could Increase The Risk of Cancer

High blood pressure is an important risk factor forone year of follow up were included.
heart disease and is treated by various antiTotal 5 clinical trials were included in the analysis,
hypertensive medications. Angiotensin receptorwhich included total of 61,590 participants. The
blockers (ARB) are established and proven medicationresearchers assessed the risk of cancer associated
for patients with high blood pressure and also,with ARBs medication. The results of meta analysis
prevent deaths due to heart disease. ARBs areshowed that there was an increased risk of cancer in
medications which blocks the effect of Angiotensin IIpatients taking ARBs compared with people not
and thus leading to dilation of blood vessels whichtaking ARBs. It was seen that risk of new cancer
results in reduction in blood pressure. However, adevelopment was 8% higher in patients taking ARBs
recent research has found that patients on thiscompared to non ARB users. Additionally, no
medication are somewhat more prone to bedifference was observed between the ARB and non
diagnosed with the cancer than those not consumingARB groups in risk of cancer related deaths.
it.In conclusion, the report said that ARBs are linked
Blood pressure lowering drugs may cause cancer. Thiswith a slightly increased risk of new cancer diagnosis.
finding was based on a systemic review and metaThis study does not prove that ARBs cause cancer,
analysis of various clinical trials. Such review providesbut the data from this systematic review is
a significant mean to find the overall effect ofsuggestive of a link with increased risk that requires
various treatments. This report included the results offurther investigation in this area.
trials done on currently available ARBs and was moreThere is no reason to panic in case you are taking
specifically focused on effects of ARBs on newany medication that are said to be causing cancer.
cancer development and deaths from cancer. VariousYou should try to visit your doctor and ask for a
scientific databases were searched and clinical trialspossible alternative that you could take. Also the risk
which included at least 100 patients were consideredis only slightly more than in people who do not take
for analysis. Special care was taken in selection ofthe ARBs. There could be other factors which could
trials as cancer is a rare adverse event which takesbe responsible for the causation of cancer apart from
longer time to develop and hence only studies withthe drugs themselves.